Effects of insulin resistance on endothelial progenitor cells and vascular repair

Clinical Science

Volumn 117, Issue 5, 2009, Pages 173-190

  Cubbon, Richard M ^a   Kahn, Matthew B ^a   Wheatcroft, Stephen B ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cardiometabolic risk; Endothelial progenitor cell (EPC); Insulin resistance; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ADIPOCYTOKINE; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; GLITAZONE DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IRBESARTAN; NITRIC OXIDE; OLMESARTAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; PRAVASTATIN; PROTEIN KINASE B; RAMIPRIL; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; VASCULOTROPIN;

ARTERY INJURY; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COUNT; CELL FUNCTION; CELL HOMING; CELL REGENERATION; CELL SPECIFICITY; CELL THERAPY; CORONARY ARTERY DISEASE; DOWN REGULATION; DRUG MECHANISM; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIMB ISCHEMIA; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL MOBILIZATION; TARGET CELL;

ADIPOKINES; ANIMALS; CELL COMMUNICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GROWTH HORMONE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; METABOLIC SYNDROME X; MICE; NITRIC OXIDE; OBESITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; STEM CELLS; TISSUE THERAPY;

EID: 70349387993     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080263     Document Type: Review

References (186)

1. Hsueh, W. A., Lyon, C. J. and Quinones, M. J. (2004) Insulin resistance and the endothelium. Am. J. Med. 117, 109-117
2. Booth, G. L., Kapral, M. K., Fung, K. and Tu, J. V. (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368, 29-36
3. Cubbon, R. M., Wheatcroft, S. B., Grant, P. J., Gale, C. P., Barth, J. H., Sapsford, R. J., Ajjan, R., Kearney, M. T. and Hall, A. S. (2007) Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur. Heart J. 28, 540-545
4. Grundy, S. M., D'Agostino, R. B., Mosca, L., Burke, G. L., Wilson, P. W., Rader, D. J., Cleeman, J. I., Roccella, E. J., Cutler, J. A. and Friedman, L. M. (2001) Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop. Circulation 104, 491-496
5. Ross R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126
6. Kim, J. A., Montagnani, M., Koh, K. K. and Quon, M. J. (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888-1904
7. Dimmeler, S. and Zeiher, A. M. (2004) Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J. Mol. Med. 82, 671-677
8. King, H., Aubert, R. E. and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431
9. Rajala, M. W. and Scherer, P. E. (2003) The adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773
10. Wheatcroft, S. B., Williams, I. L., Shah, A. M. and Kearney, M. T. (2003) Pathophysiological implications of insulin resistance on vascular endothelial function. Diabetic Med. 20, 255-268
11. Fox, C. S., Coady, S., Sorlie, P. D. Levy, D., Meigs, J.B., D'Agostino, R.B. Wilson, P.W. and Savage, P. J. (2004) Trends in cardiovascular complications of diabetes. JAMA, J. Am. Med. Assoc. 292, 2495-2499
12. Grundy, S. M., Brewer, Jr, H. B., Cleeman, J. I., Smith, Jr, S. C. and Lenfant, C. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109, 433-438
13. Unwin,N., Shaw, J., Zimmet, P. and Alberti, K. G. M. M. (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Med. 19, 708-723
14. Ford, E. S., Giles, W. H. and Dietz,W. H. (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, J. Am. Med. Assoc. 187, 356-359
15. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. and Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84, 9265-9269
16. Monastyrskaya, E., Folarin, N., Malyshev, I., Green, C. and Andreeva, L. (2002) Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 7, 127-131
17. Schafer, A., Wiesmann, F., Neubauer, S., Eigenthaler, M., Bauersachs, J. and Channon, K. M. (2004) Rapid regulation of platelet activation in vivo by nitric oxide. Circulation 109, 1819-1822
18. Tanner, F. C., Meier, P., Greutert, H., Champion, C., Nabel, E. G. and Luscher, T. F. (2000) Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101, 1982-1989
19. Harrison, D. G. (1997) Cellular and Molecular Mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100, 2153-2157
20. Levin, E. R. (1995) Endothelins. N. Engl. J. Med. 333, 356-363
21. Balletshofer, B. M., Rittig, K, Enderle,M.D., Volk A., Maerker, E., Jacob, S., Matthaei, S., Rett, K. and Haring, H. U. (2000) Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101, 1780-1784
22. Caballero, A. E., Arora, S., Saouaf, R., Lim, S. C., Smakowski, P., Park, J. Y., King,G. L., LoGerfo, F. W., Horton, E. S. and Veves, A. (1999) Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48, 1856-1862
23. Melikian, N., Chowienczyk, P., MacCarthy, P. A., Williams, I. L., Wheatcroft, S. B., Sherwood, R., Gale, C., Shah, A. M. and Kearney, M. T. (2008) Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome. Atherosclerosis 197, 375-382
24. Murphy, C., Kanaganayagam, G. S., Jiang, B., Chowienczyk, P. J., Zbinden, R., Saha, M., Rahman, S., Shah, A. M., Marber, M. S. and Kearney, M. T. (2007) Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler. Thromb. Vasc. Biol. 27, 936-942
25. Williams, I. L., Wheatcroft, S. B., Shah, A. M. and Kearney, M. T. (2002) Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int. J. Obes. Relat. Metab. Disord. 26, 754-764
26. Williams, I. L., Chowienczyk, P. J., Wheatcroft, S. B., Patel, A. G., Sherwood, R. A., Momin, A., Shah, A. M. and Kearney, M. T. (2005) Endothelial function and weight loss in obese humans. Obes. Surg. 15, 1055-1060
27. Berg, A. H., Combs, T. P. and Scherer, P. E. (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13, 84-89
28. Bhagat, K. and Vallance, P. (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96, 3042-3047
29. Busija, D.W., Miller, A. W., Katakam, P. and Erdos, B. (2006) Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance. Antioxid. Redox Signaling 8, 1131-1140
30. Duncan, E. R., Walker, S. J., Ezzat, V. A., Wheatcroft, S. B., Li, J. M., Shah, A. M. and Kearney, M. T. (2007) Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am. J. Physiol. Endocrinol. Metabol. 293, E1311-E1319
31. King, G. L. and Loeken, M. R. (2004) Hyperglycemiainduced oxidative stress in diabetic complications. Histochem. Cell Biol. 122, 333-338
32. Shulman, G. I. (2000) Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171-176
33. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S. and Lazar, M. A. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307-312
34. Wang, X. L., Zhang, L., Youker, K., Zhang, M. X., Wang, J., LeMaire, S. A., Coselli, J. S. and Shen, Y. H. (2006) Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55, 2301-2310
35. Zhu, W., Cheng, K. K., Vanhoutte, P. M., Lam, K. S. and Xu, A. (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin. Sci. 114, 361-374
36. Kearney, M. T., Duncan, E. R., Kahn, M. and Wheatcroft, S. B. (2008) Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp. Physiol. 93, 158-163
37. Wheatcroft, S. B., Shah, A. M., Li, J. M., Duncan, E., Noronha, B. T., Crossey, P. A. and Kearney, M. T. (2004) Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Diabetes 53, 2645-2652
38. Duncan, E., Crossey, P. A., Walker, S., Anilkumar, N., Poston, L., Douglas, G., Ezzat, V., Wheatcroft, S. B., Shah, A. M. and Kearney, M. T. (2008) Effect of endothelium specific insulin resistance on endothelial function in vivo. Diabetes 57, 3307-3314
39. 2+ but requires phosphorylation by Akt at Ser1179. J. Biol. Chem. 276, 30392-30398
40. Montagnani, M., Ravichandran, L. V., Chen, H., Esposito, D. L. and Quon, M. J. (2002) Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol. Endocrinol. 16, 1931-1942
41. Zeng, G. and Quon, M. J. (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98, 894-898
42. Zeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L. N., Kirby, M., Mostowski, H. and Quon, M. J. (2000) Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101, 1539-1545
43. Ishiki, M. and Klip, A. (2005) Recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 146, 5071-5078
44. Bjornholm, M., Kawano, Y., Lehtihet, M. and Zierath, J. R. (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3- kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46, 524-527
45. Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R. and Mandarino, L. J. (2000) Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105, 311-320
46. Jiang, Z. Y., Lin, Y. W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F. and King, G. L. (1999) Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest. 104, 447-457
47. Hsueh, W. A. and Law, R. E. (1999) Insulin signaling in the arterial wall. Am. J. Cardiol. 84, 21J-24J
48. Eringa, E. C., Stehouwer, C. D. A., Nieuw Amerongen, G. P., Ouwehand, L., Westerhof, N. and Sipkema, P. (2004) Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am. J. Physiol. Heart Circ. Physiol. 287, H2043-H2048
49. Asai, K., Kudej, R. K., Shen, Y. T., Yang, G. P., Takagi, G., Kudej, A. B., Geng, Y. J., Sato, N., Nazareno, J. B., Vatner, D. E. et al. (2000) Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler. Thromb. Vasc. Biol. 20, 1493-1499
50. Werner, N., Wassmann, S., Ahlers, P., Kosiol, S. and Nickenig, G. (2006) Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 26, 112-116
51. Asahara, T.,Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M. and Isner, J. M. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221-228
52. Shi, Q., Rafii, S., Wu, M. H., Wijelath, E. S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Mohle, R., Sauvage, L. R. et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367
53. Aicher, A., Rentsch, M., Sasaki, K., Ellwart, J.W., Fandrich, F., Siebert, R., Cooke, J. P., Dimmeler, S. and Heeschen, C. (2007) Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res. 100, 581-589
54. Aicher, A., Zeiher, A. M. and Dimmeler, S. (2005) Mobilizing endothelial progenitor cells. Hypertension 45, 321-325
55. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M. and Isner, J. M. (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18, 3964-3972
56. Gallagher, K. A., Liu, Z. J., Xiao, M., Chen, H., Goldstein, L. J., Buerk, D. G., Nedeau, A., Thom, S. R. and Velazquez, O. C. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α. J. Clin. Invest 117, 1249-1259
57. Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., Levine, J. P. and Gurtner, G. C. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786
58. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P. and Gurtner, G. C. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864
59. Hur, J., Yoon, C. H., Kim, H. S., Choi, J. H., Kang, H. J., Hwang, K. K., Oh, B.H., Lee M.M. and Park, Y.B. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 288-293
60. Sieveking, D. P., Buckle, A., Celermajer, D. S. and Ng, M. K. C. (2008) strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol. 51, 660-668
61. Wassmann, S., Werner, N., Czech, T. and Nickenig, G. (2006) Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ. Res. 99, E74-E83
62. Rauscher, F. M., Goldschmidt-Clermont, P. J., Davis, B. H., Wang, T., Gregg, D., Ramaswami, P., Pippen, A. M., Annex, B. H., Dong, C. and Taylor, D. A. (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108, 457-463
63. George, J., Afek, A., Abashidze, A., Shmilovich, H., Deutsch, V., Kopolovich, J., Miller, H. and Keren, G. (2005) Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 25, 2636-2641
64. Karra, R., Vemullapalli, S., Dong, C., Herderick, E. E., Song, X., Slosek, K., Nevins, J. R., West, M., Goldschmidt-Clermont, P. J. and Seo, D. (2005) Molecular evidence for arterial repair in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 102, 16789-16794
65. Hill, J. M., Zalos, G., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A. and Finkel, T. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600
66. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Bohm, M. and Nickenig, G. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999-1007
67. Werner, N., Junk, S., Laufs, U., Link, A., Walenta, K., Bohm, M. and Nickenig, G. (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93, 17-24
68. Foteinos, G., Hu, Y., Xiao, Q., Metzler, B. and Xu, Q. (2008) Rapid endothelial turnover in atherosclerosisprone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation 117, 1856-1863
69. Egan, C. G., Lavery, R., Caporali, F., Fondelli, C., Laghi-Pasini, F., Dotta, F. and Sorrentino, V. (2008) Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. Diabetologia 51, 1296-1305
70. Fadini, G. P., Miorin, M., Facco, M., Bonamico, S., Baesso, I., Grego, F., Menegolo, M., de Kreutzenberg, S. V., Tiengo, A., Agostini, C. and Avogaro, A. (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 45, 1449-1457
71. Kusuyama, T., Omura, T., Nishiya, D., Enomoto, S., Matsumoto, R., Takeuchi, K., Yoshikawa, J. and Yoshiyama, M. (2006) Effects of treatment for diabetes mellitus on circulating vascular progenitor cells. J. Pharmacol. Sci. 102, 96-102
72. Fadini, G. P., Pucci, L., Vanacore, R., Baesso, I., Penno, G., Balbarini, A., Di Stefano, R., Miccoli, R., de Kreutzenberg, S., Coracina, A. et al. (2007) Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 50, 2156-2163
73. Fadini, G. P., de Kreutzenberg, S. V., Coracina, A., Baesso, I., Agostini, C., Tiengo, A. and Avogaro, A. (2006) Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur. Heart J. 27, 2247-2255
74. Westerweel, P. E., Visseren, F. L., Hajer, G. R., Olijhoek, J. K., Hoefer, I. E., de Bree, P., Rafii, S., Doevendans, P. A. and Verhaar, M. C. (2008) Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur. Heart J. 29, 2808-2817
75. Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-Ihling, K., Zeiher, A. M. and Dimmeler, S. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9, 1370-1376
76. Aicher, A., Heeschen, C. and Dimmeler, S. (2004) The role of NOS3 in stem cell mobilization. Trends Mol. Med. 10, 421-425
77. Hristov, M., Erl, W. and Weber, P. C. (2003) Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 23, 1185-1189
78. Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rütten, H., Fichtlscherer, S., Martin, H. and Zeiher, A. M. (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108, 391-397
79. Thum, T., Hoeber, S., Froese, S., Klink, I., Stichtenoth, D. O., Galuppo, P., Jakob, M., Tsikas, D., Anker, S. D., Poole-Wilson, P. A. et al. (2007) Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ. Res. 100, 434-443
80. Werner, C., Kamani, C. H., Gensch, C., Bohm, M. and Laufs, U. (2007) The peroxisome proliferator-activated receptor-γ agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 56, 2609-2615
81. Urao, N., Okigaki, M., Yamada, H., Aadachi, Y., Matsuno, K., Matsui, A., Matsunaga, S., Tateishi, K., Nomura, T., Takahashi, T. et al. (2006) Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ. Res. 98, 1405-1413
82. Ii, M., Takenaka, H., Asai, J., Ibusuki, K., Mizukami, Y., Maruyama, K., Yoon, Y. S., Wecker, A., Luedemann, C., Eaton, E. et al. (2006) Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ. Res. 98, 697-704
83. Badillo, A. T., Chung, S., Zhang, L., Zoltick, P. and Liechty, K. W. (2007) Lentiviral gene transfer of SDF-1α to wounds improves diabetic wound healing. J. Surg. Res. 143, 35-42
84. Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G. and Baron, A. D. (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97, 2601-2610
85. Laufs, U., La Fata, V., Plutzky, J. and Liao, J. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135
86. Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jürgens, K., Miche, E., Böhm, M. and Nickenig, G. (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109, 220-226
87. Segal, M. S., Shah, R., Afzal, A., Perrault, C. M., Chang, K., Schuler, A., Beem, E., Shaw, L. C., Li Calzi, S., Harrison, J. K. et al. (2006) Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55, 102-109
88. Thum, T., Tsikas, D., Stein, S., Schultheiss, M., Eigenthaler, M., Anker, S. D., Poole-Wilson, P. A., Ertl, G. and Bauersachs, J. (2005) Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J. Am. Coll. Cardiol. 46, 1693-1701
89. Ellger, B., Richir, M. C., van Leeuwen, P. A., Debaveye, Y., Langouche, L., Vanhorebeek, I., Teerlink, T. and Van den Berghe, G. (2008) Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Endocrinology 149, 3148-3157
90. Ackah, E., Yu, J., Zoellner, S., Iwakiri, Y., Skurk, C., Shibata, R., Ouchi, N., Easton, R. M., Galasso, G., Birnbaum, M. J., Walsh, K. and Sessa, W. C. (2005) Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest. 115, 2119-2127
91. Han, J. K., Lee, H. S., Yang, H. M., Hur, J., Jun, S. I., Kim, J. Y., Cho, C. H., Koh, G. Y., Peters, J. M., Park, K. W., Cho, H. J., Lee, H. Y. et al. (2008) Peroxisome proliferator-activated receptor-δ agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Circulation 118, 1021-1033
92. Zheng, H., Dai, T., Zhou, B., Zhu, J., Huang, H., Wang, M. and Fu, G. (2008) SDF-1α/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis 201, 36-42
93. Seeger, F. H., Haendeler, J., Walter, D. H., Rochwalsky, U., Reinhold, J., Urbich, C., Rössig, L., Corbaz, A., Chvatchko, Y., Zeiher, A. M. and Dimmeler, S. (2005) p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111, 1184-1191
94. Tilg, H. and Moschen, A. R. (2008) Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 14, 222-231
95. Tousoulis, D., Antoniades, C., Koumallos, N. and Stefanadis, C. (2006) Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev. 17, 225-233
96. Verma, S., Kuliszewski, M. A., Li, S. H., Szmitko, P. E., Zucco, L., Wang, C. H., Badiwala, M. V., Mickle, D. A., Weisel, R. D., Fedak, P. W. et al. (2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109, 2058-2067
97. Rabelink, T. J., de Boer, H. C., de Koning, E. J. and van Zonneveld, A. J. (2004) Endothelial progenitor cells: more than an inflammatory response? Arterioscler. Thromb. Vasc. Biol. 24, 834-838
98. Andreou, I., Tousoulis, D., Tentolouris, C., Antoniades, C. and Stefanadis, C. (2006) Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives. Atherosclerosis 189, 247-254
99. Momin, A. U., Melikian, N., Shah, A. M., Grieve, D. J., Wheatcroft, S. B., John, L., El Gamel, A., Desai, J. B., Nelson, T., Driver, C. et al. (2006) Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. Eur. Heart J. 27, 2294-2299
100. Vecchione, C., Maffei, A., Colella, S., Aretini, A., Poulet, R., Frati, G., Gentile, M. T., Fratta, L., Trimarco, V., Trimarco, B. and Lembo, G. (2002) Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51, 168-173
101. Muniyappa, R., Walsh, M. F., Rangi, J. S., Zayas, R. M., Standley, P. R., Ram, J. L. and Sowers, J. R. (1997) Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci. 61, 925-931
102. Wolk, R., Deb, A., Caplice, N. M. and Somers, V. K. (2005) Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 183, 131-139
103. Schroeter, M. R., Leifheit, M., Sudholt, P., Heida, N. M., Dellas, C., Rohm, I., Alves, F., Zientkowska, M., Rafail, S., Puls, M. et al. (2008) Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ. Res. 103, 536-544
104. Myers, M. G., Cowley, M. A. and Munzberg, H. (2008) Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70, 537-556
105. Hopkins, T. A., Ouchi, N., Shibata, R. and Walsh, K. (2007) Adiponectin actions in the cardiovascular system. Cardiovasc. Res. 74, 11-18
106. Chen, H., Montagnani, M., Funahashi, T., Shimomura, I. and Quon, M. J. (2003) Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278, 45021-45026
107. Shibata, R., Skurk, C., Ouchi, N., Galasso, G., Kondo, K., Ohashi, T., Shimano, M., Kihara, S., Murohara, T. and Walsh, K. (2008) Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett. 582, 1607-1612
108. Matsuo, Y., Imanishi, T., Kuroi, A., Kitabata, H., Kubo, T., Hayashi, Y., Tomobuchi, Y. and Akasaka, T. (2007) Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease. Circ. J. 71, 1376-1382
109. Thum, T., Fraccarollo, D., Galuppo, P., Tsikas, D., Frantz, S., Ertl, G. and Bauersachs, J. (2006) Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc. Res. 70, 50-60
110. Thum, T., Fraccarollo, D., Schultheiss, M., Froese, S., Galuppo, P., Widder, J. D., Tsikas, D., Ertl, G. and Bauersachs, J. (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56, 666-674
111. Urbich, C., Knau, A., Fichtlscherer, S., Walter, D. H., Brühl, T., Potente, M., Hofmann, W. K., de Vos, S., Zeiher, A. M. and Dimmeler, S. (2005) FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J. 19, 974-976
112. Thum, T., Fraccarollo, D., Thum, S., Schultheiss, M., Daiber, A., Wenzel, P., Munzel, T., Ertl, G. and Bauersachs, J. (2007) Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. Arterioscler. Thromb. Vasc. Biol. 27, 748-754
113. Galasso, G., Schiekofer, S., Sato, K., Shibata, R., Handy, D. E., Ouchi, N., Leopold, J. A., Loscalzo, J. and Walsh, K. (2006) Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ. Res. 98, 254-261
114. Awad, O., Jiao, C., Ma, N., Dunnwald, M. and Schatteman, G. C. (2005) Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 23, 575-583
115. Sorrentino, S. A., Bahlmann, F. H., Besler, C., Müller, M., Schulz, S., Kirchhoff, N., Doerries, C., Horváth, T., Limbourg, A., Limbourg, F. et al. (2007) Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus:restoration by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 116, 163-173
116. Ceradini, D. J., Yao, D., Grogan, R. H., Callaghan, M. J., Edelstein, D., Brownlee, M. and Gurtner, G. C. (2008) Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J. Biol. Chem. 283, 10930-10938
117. Ohshima, M., Li, T. S., Kubo, M., Qin, S. L. and Hamano, K. (2009) Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells. Circ. J. 73, 162-166
118. Ushio-Fukai, M. (2006) Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 71, 226-235
119. Urao, N., Inomata, H., Razvi, M., Kim, H. W., Wary, K., McKinney, R., Fukai, T. and Ushio-Fukai, M. (2008) Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ. Res. 103, 212-220
120. Takaya, T., Hirata, K., Yamashita, T., Shinohara, M., Sasaki, N., Inoue, N., Yada, T., Goto, M., Fukatsu, A., Hayashi, T. et al. (2007) A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. Arterioscler. Thromb. Vasc. Biol. 27, 1632-1637
121. Schmidt, T. S. and Alp, N. J. (2007) Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin. Sci. 113, 47-63
122. Bauersachs, J. and Thum, T. (2007) Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches. Eur. J. Clin. Invest. 37, 603-606
123. Humpert, P. M., Neuwirth, R., Battista, M. J., Voronko, O., von Eynatten, M., Konrade, I., Rudofsky, Jr, G., Wendt, T., Hamann, A., Morcos, M. et al. (2005) SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. Diabetes Care 28, 934-936
124. + progenitor cells mobilized into peripheral blood in humans. Br. J. Haematol. 113, 247-250
125. Humpert, P. M., Djuric, Z., Zeuge, U., Oikonomou, D., Seregin, Y., Laine, K., Eckstein, V., Nawroth, P. P. and Bierhaus, A. (2008) Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling. Mol. Med. 14, 301-308
126. Walsh, M. F., Barazi, M., Pete, G., Muniyappa, R., Dunbar, J. C. and Sowers, J. R. (1996) Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137, 1798-1803
127. Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J. and Jorgensen, T. (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106, 939-944
128. Laufs, U., Urhausen, A., Werner, N., Scharhag, J., Heitz, A., Kissner, G., Böhm, M., Kindermann, W. and Nickenig, G. (2005) Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur. J. Cardiovasc. Prev. Rehabil. 12, 407-414
129. Sandri, M., Adams, V., Gielen, S., Linke, A., Lenk, K., Kränkel, N., Lenz, D., Erbs, S., Scheinert, D., Mohr, F. W. et al. (2005) Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111, 3391-3399
130. Nowak, A., Pilaczynska-Szczesniak, L., Sliwicka, E., Deskur-Smielecka, E., Karolkiewicz, J. and Piechowiak, A. (2008) Insulin resistance and glucose tolerance in obese women: the effects of a recreational training program. J. Sports Med. Phys. Fitness 48, 252-258
131. Hamdy, O., Ledbury, S., Mullooly, C., Jarema, C., Porter, S., Ovalle, K., Moussa, A., Caselli, A., Caballero, A. E., Economides, P. A. et al. (2003) Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26, 2119-2125
132. Müller-Ehmsen, J., Braun, D., Schneider, T., Pfister, R., Worm, N., Wielckens, K., Scheid, C., Frommolt, P. and Flesch, M. (2008) Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur. Heart J. 29, 1560-1568
133. Siegel, D. and Swislocki, A. L. (2007) Effects of antihypertensives on glucose metabolism. Metab. Syndr. Relat. Disord. 5, 211-219
134. Wang, C. H., Verma, S., Hsieh, I. C., Chen, Y. J., Kuo, L. T., Yang, N. I., Wang, S. Y., Wu, M. Y., Hsu, C. M., Cheng, C. W. and Cherng, W. J. (2006) Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J. Mol. Cell. Cardiol. 41, 34-43
135. Min, T. Q., Zhu, C. J., Xiang, W. X., Hui, Z. J. and Peng, S. Y. (2004) Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 18, 203-209
136. Bahlmann, F. H., de Groot, K., Mueller, O., Hertel, B., Haller, H. and Fliser, D. (2005) Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45, 526-529
137. Chen, M., Ichiki, T., Ohtsubo, H., Imayama, I., Inanaga, K., Miyazaki, R. and Sunagawa, K. (2007) Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance. Hypertens. Res. 30, 971-978
138. Fujishima, S., Ohya, Y., Nakamura, Y., Onaka, U., Abe, I. and Fujishima, M. (1998) Troglitazone, an insulin sensitizer, increases forearm blood flow in humans. Am. J. Hypertens. 11, 1134-1137
139. Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E.,
140. Erdmann, E., Dormandy, J. A., Charbonnel, B., Massi-Benedetti, M., Moules, I. K. and Skene, A. M. (2007) The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study. J. Am. Coll. Cardiol. 49, 1772-1780
141. Pistrosch, F., Herbrig, K., Oelschlaegel, U., Richter, S., Passauer, J., Fischer, S. and Gross, P. (2005) PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183, 163-167
142. Wang, C. H., Ciliberti, N., Li, S. H., Szmitko, P. E., Weisel, R. D., Fedak, P. W., Al-Omran, M., Cherng, W. J., Li, R. K., Stanford, W. L. and Verma, S. (2004) Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109, 1392-1400
143. Wang, C. H., Ting, M. K., Verma, S., Kuo, L. T., Yang, N. I., Hsieh, I. C., Wang, S. Y., Hung, A. and Cherng, W. J. (2006) Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am. Heart J. 152, 1051-1058
144. Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K. et al. (2003) Activation of peroxisome proliferator-activated receptor a induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. U.S.A. 100, 15924-15929
145. Malmberg, K. (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br. Med. J. 314, 1512-1515
146. Fadini, G. P., Baesso, I., Agostini, C., Cuccato, E., Nardelli, G. B., Lapolla, A. and Avogaro, A. (2008) Maternal insulin therapy increases fetal endothelial progenitor cells during diabetic pregnancy. Diabetes Care 31, 808-810
147. Fadini, G. P., Sartore, S., Schiavon, M., Albiero, M., Baesso, I., Cabrelle, A., Agostini, C. and Avogaro, A. (2006) Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49, 3075-3084
148. Fleissner, F. and Thum, T. (2008) The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function. Mol. Med. 14, 235-237
149. Strehlow, K., Werner, N., Berweiler, J., Link, A., Dirnagl, U., Priller, J., Laufs, K., Ghaeni, L., Milosevic, M., Böhm, M. and Nickenig, G. (2003) Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107, 3059-3065
150. Iwakura, A., Luedemann, C., Shastry, S., Hanley, A., Kearney, M., Aikawa, R., Isner, J. M., Asahara, T. and Losordo, D. W. (2003) Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108, 3115-3121
151. Fontaine, V., Filipe, C., Werner, N., Gourdy, P., Billon, A., Garmy-Susini, B., Brouchet, L., Bayard, F., Prats, H., Doetschman, T. et al. (2006) Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. Am. J. Pathol. 169, 1855-1862
152. Zhao, X., Huang, L., Yin, Y., Fang, Y., Zhao, J. and Chen, J. (2008) Estrogen induces endothelial progenitor cells proliferation and migration by estrogen receptors and PI3K-dependent pathways. Microvasc. Res. 75, 45-52
153. Imanishi, T., Hano, T. and Nishio, I. (2005) Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J. Hypertens. 23, 1699-1706
154. Fadini, G. P., de Kreutzenberg, S., Albiero, M., Coracina, A., Pagnin, E., Baesso, I., Cignarella, A., Bolego, C., Plebani, M., Nardelli, G. B., Sartore, S. et al. (2008) Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler. Thromb. Vasc. Biol. 28, 997-1004
155. Lemieux, C., Cloutier, I. and Tanguay, J. F. (2008) Menstrual cycle influences endothelial progenitor cell regulation: a link to gender differences in vascular protection? Int. J. Cardiol., doi:10.1016/ j.ijcard.2008.04.054
156. Yoshioka, T., Takahashi, M., Shiba, Y., Suzuki, C., Morimoto, H., Izawa, A., Ise, H. and Ikeda, U. (2006) Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc. Res. 70, 61-69
157. Huang, P., Li, S., Han, M., Xiao, Z., Yang, R. and Han, Z. C. (2005) Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 28, 2155-2160
158. Hill, J. M., Syed, M. A., Arai, A. E., Powell, T. M., Paul, J. D., Zalos, G., Read, E. J., Khuu, H. M., Leitman, S. F., Horne, M. et al. (2005) Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol. 46, 1643-1648
159. Assmus, B., Schächinger, V., Teupe, C., Britten, M., Lehmann, R., Döbert, N., Grünwald, F., Aicher, A., Urbich, C., Martin, H. et al. (2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106, 3009-3017
160. Kang, H. J., Kim, H. S., Zhang, S. Y., Park, K. W., Cho, H. J., Koo, B. K., Kim, Y. J., Soo Lee, D., Sohn, D. W., Han, K. S. et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363, 751-756
161. Kalka, C., Tehrani, H., Laudenberg, B., Vale, P. R., Isner, J. M., Asahara, T. and Symes, J. F. (2000) VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann. Thorac. Surg. 70, 829-834
162. Assmus, B., Honold, J., Schächinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., Teupe, C., Pistorius, K., Martin, H., Abolmaali, N. D. et al. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232
163. Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., Kalantzi, M., Herbots, L., Sinnaeve, P., Dens, J. et al. (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113-121
164. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Fjeld, J. G. et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355, 1199-1209
165. Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W. et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355, 1210-1221
166. Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D. et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148
167. Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W. M., Silver, M., Kearney, M., Li, T., Isner, J. M and Asahara, T. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U.S.A. 97, 3422-3427
168. Kawamoto, A., Gwon, H. C., Iwaguro, H., Yamaguchi, J. I., Uchida, S., Masuda, H., Silver, M., Ma, H., Kearney, M., Isner, J. M. and Asahara, T. (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637
169. Wassmann, S., Werner, N., Czech, T. and Nickenig, G. (2006) Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ. Res. 99, e74-e83
170. Sasaki, K., Heeschen, C., Aicher, A., Ziebart, T., Honold, J., Urbich, C., Rossig, L., Koehl, U., Koyanagi, M., Mohamed, A. et al. (2006) Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl. Acad. Sci. U.S.A. 103, 14537-14541
171. Iwaguro, H., Yamaguchi, J., Kalka, C., Murasawa, S., Masuda, H., Hayashi, S., Silver, M., Li, T., Isner, J. M. and Asahara, T. (2002) Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105, 732-738
172. Hirschi, K. K., Ingram, D. A. and Yoder, M. C. (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28, 1584-1595
173. Yoder, M. C., Mead, L. E., Prater, D., Krier, T. R., Mroueh, K. N., Li, F., Krasich, R., Temm, C. J., Prchal, J. T. and Ingram, D. A. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-1809
174. Ingram, D. A., Mead, L. E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., Pollok, K., Ferkowicz, M. J., Gilley, D. and Yoder, M. C. (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104, 2752-2760
175. Ingram, D. A., Mead, L. E., Moore, D. B., Woodard, W., Fenoglio, A. and Yoder, M. C. (2005) Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105, 2783-2786
176. Chen, Y. H., Lin, S. J., Lin, F. Y., Wu, T. C., Tsao, C. R., Huang, P. H., Liu, P. L., Chen, Y. L. and Chen, J. W. (2007) High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 56, 1559-1568
177. Ingram, D. A., Lien, I. Z., Mead, L. E., Estes, M., Prater, D. N., Derr-Yellin, E., DiMeglio, L. A. and Haneline, L. S. (2008) in vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function. Diabetes 57, 724-731
178. Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, Jr, D. C., Bigger, J. T., Buse, J. B., Cushman, W. C., Genuth, S., Ismail-Beigi, F., Grimm, Jr, R. H. et al. (2008) Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545-2559
179. Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., Marre, M., Cooper, M., Glasziou, P., Grobbee, D. et al. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358, 2560-2572
180. Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R. et al. (2009) Glucose control and vascular complications in veterans with Type 2 diabetes. N. Engl. J. Med. 360, 129-139
181. Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. and Neil, H. A. (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577-1589
182. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865
183. Kahn, M., Cubbon, R. M., Abbas, A., Viswambharan, H., Yuldasheva, N., Kearney, M. and Wheatcroft, S. B. (2008) Insulin resistance reduces circulating endothelial progenitor cells and delays endothelial repair following vascular injury. Diabetes Vasc. Dis. Res. 5, 240
184. Baumgartl, J., Baudler, S., Scherner, M., Babaev, V., Makowski, L., Suttles, J., McDuffie, M., Tobe, K., Kadowaki, T., Fazio, S. et al. (2006) Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Cell Metab. 3, 247-256
185. Han, S., Liang, C. P., DeVries-Seimon, T., Ranalletta, M., Welch, C. L., Collins-Fletcher, K., Accili, D., Tabas, I. and Tall, A. R. (2006) Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 3, 257-266
186. Burke, G. L., Bertoni, A. G., Shea, S., Tracy, R., Watson, K. E., Blumenthal, R. S., Chung, H. and Carnethon, M. R. (2008) The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch. Intern. Med. 168, 928-935